These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19752280)

  • 1. Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.
    Barrow K; Kwon DH
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5150-4. PubMed ID: 19752280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single amino acid substitution in PmrB is associated with polymyxin B resistance in clinical isolate of Pseudomonas aeruginosa.
    Abraham N; Kwon DH
    FEMS Microbiol Lett; 2009 Sep; 298(2):249-54. PubMed ID: 19663916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Schurek KN; Sampaio JL; Kiffer CR; Sinto S; Mendes CM; Hancock RE
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4345-51. PubMed ID: 19635950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates.
    Lee JY; Ko KS
    Diagn Microbiol Infect Dis; 2014 Mar; 78(3):271-6. PubMed ID: 24412662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Role of Two-Component Regulatory Systems (
    Owusu-Anim D; Kwon DH
    Adv Microbiol; 2012 Mar; 2(1):. PubMed ID: 24349887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients.
    Moskowitz SM; Brannon MK; Dasgupta N; Pier M; Sgambati N; Miller AK; Selgrade SE; Miller SI; Denton M; Conway SP; Johansen HK; Høiby N
    Antimicrob Agents Chemother; 2012 Feb; 56(2):1019-30. PubMed ID: 22106224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients.
    Miller AK; Brannon MK; Stevens L; Johansen HK; Selgrade SE; Miller SI; Høiby N; Moskowitz SM
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5761-9. PubMed ID: 21968359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems.
    Gutu AD; Sgambati N; Strasbourger P; Brannon MK; Jacobs MA; Haugen E; Kaul RK; Johansen HK; Høiby N; Moskowitz SM
    Antimicrob Agents Chemother; 2013 May; 57(5):2204-15. PubMed ID: 23459479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated isolation of Pseudomonas aeruginosa isolates resistant to both polymyxins and carbapenems from 1 patient.
    Lee JY; Lim MH; Heo ST; Ko KS
    Diagn Microbiol Infect Dis; 2012 Mar; 72(3):267-71. PubMed ID: 22217703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China.
    Lin J; Xu C; Fang R; Cao J; Zhang X; Zhao Y; Dong G; Sun Y; Zhou T
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive and Mutational Responses to Peptide Dendrimer Antimicrobials in Pseudomonas aeruginosa.
    Ben Jeddou F; Falconnet L; Luscher A; Siriwardena T; Reymond JL; van Delden C; Köhler T
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulating polymyxin resistance in Gram-negative bacteria: roles of two-component systems PhoPQ and PmrAB.
    Huang J; Li C; Song J; Velkov T; Wang L; Zhu Y; Li J
    Future Microbiol; 2020 Apr; 15(6):445-459. PubMed ID: 32250173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and -resistant Pseudomonas aeruginosa.
    Hermes DM; Pormann Pitt C; Lutz L; Teixeira AB; Ribeiro VB; Netto B; Martins AF; Zavascki AP; Barth AL
    J Med Microbiol; 2013 Aug; 62(Pt 8):1184-1189. PubMed ID: 23699064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa high-level resistance to polymyxins and other antimicrobial peptides requires cprA, a gene that is disrupted in the PAO1 strain.
    Gutu AD; Rodgers NS; Park J; Moskowitz SM
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5377-87. PubMed ID: 26100714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of Metabolic and Lipid Profiles in Polymyxin-Resistant Pseudomonas aeruginosa.
    Han ML; Zhu Y; Creek DJ; Lin YW; Anderson D; Shen HH; Tsuji B; Gutu AD; Moskowitz SM; Velkov T; Li J
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa.
    McPhee JB; Lewenza S; Hancock RE
    Mol Microbiol; 2003 Oct; 50(1):205-17. PubMed ID: 14507375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS.
    Fernández L; Gooderham WJ; Bains M; McPhee JB; Wiegand I; Hancock RE
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3372-82. PubMed ID: 20547815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PmrAB and PhoPQ Variants in Colistin-Resistant Enterobacter spp. Isolates in Korea.
    Hong YK; Ko KS
    Curr Microbiol; 2019 May; 76(5):644-649. PubMed ID: 30891622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins.
    van der Heijden IM; Levin AS; De Pedri EH; Fung L; Rossi F; Duboc G; Barone AA; Costa SF
    Ann Clin Microbiol Antimicrob; 2007 Aug; 6():8. PubMed ID: 17697363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic variations in polymyxin-resistant Pseudomonas aeruginosa clinical isolates and their effects on polymyxin resistance.
    Liang Y; Li J; Xu Y; He Y; Jiang B; Wu C; Shan B; Shi H; Song G
    Braz J Microbiol; 2023 Jun; 54(2):655-664. PubMed ID: 36930447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.